A 65-year old human immunodeficiency virus (HIV)-uninfected man presented to the ophthalmology department with 3-week history of progressive deterioration of his right eyesight and a visual field abnormality. He also complained of 3-month of a painless ulcer on his dorsal penile shafts with 3-week of diffuse, symmetric skin erythema involving his entire trunk, bilateral palms and soles. His serum Venereal Disease Research Laboratory titer was 1:64 and Treponema Pallidum Hemagglutination (TPHA) titer was 1:5120. Examination of the cerebrospinal fluid revealed normal cell count of 3/μL, and glucose of 65 mg/dL, but slightly elevated protein of 52 mg/dL and positive TPHA of 1:8. Ophthalmologic examination demonstrated right papilledema and optic disk hemorrhage with leakage of contrast medium that was compatible with optic neuritis ([Fig. 1](#fig0005){ref-type="fig"}). In addition, magnetic resonance imaging showed edema of his right optic nerve ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 1Ophthalmologic exam revealed right papilledema, optic disk hemorrhage and leakage of contrast medium on fundoscopy.Fig. 1Fig. 2MRI showing edema of the right optic nerve.Fig. 2

Optic neuropathy can occur in secondary syphilis, although it is likely underestimated as it may be overlooked [@bib0005]. Ocular syphilis is less common in HIV-uninfected healthy patients compared to those with HIV infection [@bib0010], but clinicians should be aware that the presence of diminished visual acuity in syphilitic patients is strongly suggestive of central nervous system involvement [@bib0015]. Syphilic optic neuritis can proceed to rapid visual dysfunction [@bib0020]. Our patient was treated with penicillin G 4 million units intravenously every 4 h for 14 days along with oral prednisolone 1 mg/kg daily, and his skin lesions and visual disturbance gradually improved. As delayed diagnosis can lead to irreversible visual loss, early assessment and treatment is of paramount importance [@bib0025].
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